Artigo
Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology
Fecha
2011-01-01Registro en:
Veterinary Pathology. Thousand Oaks: Sage Publications Inc, v. 48, n. 1, p. 7-18, 2011.
0300-9858
10.1177/0300985810377187
WOS:000287200500002
9795829022108105
Autor
Michigan State University
NCI
Univ Sydney
Charles Sturt Univ
Univ Florida
BrightHeart Vet Ctr
University of Guelph
Universidade Federal de Minas Gerais (UFMG)
Univ Padua
N Carolina State Univ
ARUP Labs
Univ Complutense Madrid
Univ Penn
Hills Pet Nutr Inc
Univ Missouri
Swedish Univ Agr Sci
Colorado State Univ
Univ Utrecht
Universidade Estadual Paulista (Unesp)
Purdue Univ
Armed Forces Inst Pathol
Cornell Univ
MPI Res
Idexx Reference Labs
Univ Calif Davis
Antech Diagnost
Univ Tokyo
Univ Georgia
Univ Bologna
Bridge Pathol Ltd
Pfizer Ltd
NSG Pathol
VDx Vet Diagnost
Ohio State Univ
Yager Best Histovet
Resumen
There is an increasing need for more accurate prognostic and predictive markers in veterinary oncology because of an increasing number of treatment options, the increased financial costs associated with treatment, and the emotional stress experienced by owners in association with the disease and its treatment. Numerous studies have evaluated potential prognostic and predictive markers for veterinary neoplastic diseases, but there are no established guidelines or standards for the conduct and reporting of prognostic studies in veterinary medicine. This lack of standardization has made the evaluation and comparison of studies difficult. Most important, translating these results to clinical applications is problematic. To address this issue, the American College of Veterinary Pathologists' Oncology Committee organized an initiative to establish guidelines for the conduct and reporting of prognostic studies in veterinary oncology. The goal of this initiative is to increase the quality and standardization of veterinary prognostic studies to facilitate independent evaluation, validation, comparison, and implementation of study results. This article represents a consensus statement on the conduct and reporting of prognostic studies in veterinary oncology from veterinary pathologists and oncologists from around the world. These guidelines should be considered a recommendation based on the current state of knowledge in the field, and they will need to be continually reevaluated and revised as the field of veterinary oncology continues to progress. As mentioned, these guidelines were developed through an initiative of the American College of Veterinary Pathologists' Oncology Committee, and they have been reviewed and endorsed by the World Small Animal Veterinary Association.